Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · IEX Real-Time Price · USD
9.07
+0.15 (1.68%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Zynex Revenue
Zynex had revenue of $188.68M in the twelve months ending March 31, 2024, with 11.48% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $46.53M with 10.34% year-over-year growth. In the year 2023, Zynex had annual revenue of $184.32M with 16.54% growth.
Revenue (ttm)
$188.68M
Revenue Growth
+11.48%
P/S Ratio
1.53
Revenue / Employee
$171,530
Employees
1,100
Market Cap
288.20M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184.32M | 26.16M | 16.54% |
Dec 31, 2022 | 158.17M | 27.87M | 21.39% |
Dec 31, 2021 | 130.30M | 50.18M | 62.63% |
Dec 31, 2020 | 80.12M | 34.65M | 76.20% |
Dec 31, 2019 | 45.47M | 13.56M | 42.47% |
Dec 31, 2018 | 31.92M | 8.49M | 36.21% |
Dec 31, 2017 | 23.43M | 10.12M | 76.01% |
Dec 31, 2016 | 13.31M | 1.67M | 14.36% |
Dec 31, 2015 | 11.64M | 524.00K | 4.71% |
Dec 31, 2014 | 11.12M | -10.57M | -48.73% |
Dec 31, 2013 | 21.68M | -25.47M | -54.01% |
Dec 31, 2012 | 47.15M | 7.48M | 18.84% |
Dec 31, 2011 | 39.68M | 11.19M | 39.29% |
Dec 31, 2010 | 28.49M | 7.58M | 36.23% |
Dec 31, 2009 | 20.91M | 7.64M | 57.62% |
Dec 31, 2008 | 13.27M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amarin Corporation | 277.46M |
Kamada | 149.55M |
Alimera Sciences | 90.22M |
Poseida Therapeutics | 82.50M |
Enanta Pharmaceuticals | 72.88M |
Cartesian Therapeutics | 25.91M |
XOMA Corporation | 5.81M |
Opthea | 385.28K |
ZYXI News
- 22 days ago - Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 - PRNewsWire
- 7 weeks ago - Zynex to Present at the RBC Capital Markets Global Healthcare Conference - PRNewsWire
- 2 months ago - Zynex Executives Recognized Among Top 25 in Medical Technology - PRNewsWire
- 2 months ago - Zynex Reports First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Zynex Sets First Quarter 2024 Earnings Call - PRNewsWire
- 3 months ago - Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award - PRNewsWire
- 4 months ago - Zynex Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 4 months ago - Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call - PRNewsWire